Health Catalyst, Inc. (HCAT)
| Market Cap | 2.21B |
| Revenue (ttm) | 199.58M |
| Net Income (ttm) | -125.90M |
| Shares Out | 43.87M |
| EPS (ttm) | -28.31 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | May 13 |
| Last Price | $47.94 |
| Previous Close | $48.16 |
| Change ($) | -0.23 |
| Change (%) | -0.47% |
| Day's Open | 48.24 |
| Day's Range | 47.12 - 49.30 |
| Day's Volume | 256,590 |
| 52-Week Range | 25.68 - 59.10 |
Health Catalyst (HCAT) delivered earnings and revenue surprises of 53.85% and 3.25%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
SALT LAKE CITY, May 06, 2021 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, to...
Health Catalyst (HCAT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
SALT LAKE CITY, April 20, 2021 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, ...
A Relative Strength Rating upgrade for Health Catalyst shows improving technical performance. Will it continue?
SALT LAKE CITY, March 31, 2021 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst") (NASDAQ: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, tod...
SALT LAKE CITY, March 10, 2021 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst,") (Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, to...
SOUTH JORDAN, Utah, Feb. 26, 2021 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organization...
Shares of Health Catalyst (NASDAQ:HCAT) decreased in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share increased 23.81% year over year to ($0.16), which be...
SOUTH JORDAN, Utah, Feb. 25, 2021 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organization...
Health Catalyst (HCAT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
SALT LAKE CITY, Feb. 09, 2021 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, w...
SALT LAKE CITY, Jan. 11, 2021 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today...
SALT LAKE CITY, Dec. 22, 2020 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, t...
US healthcare costs have ballooned in recent years, yet at least 25% of that spending is due to general inefficiency. Health Catalyst provides a way for healthcare organizations to manage their data and...
Health Catalyst (HCAT) saw a big move last session, as its shares jumped more than 5% on the day, amid huge volumes.
SALT LAKE CITY, Nov. 24, 2020 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, t...
Health Catalyst, Inc. (HCAT) CEO Dan Burton on Q3 2020 Results - Earnings Call Transcript
Health Catalyst (HCAT) delivered earnings and revenue surprises of 22.22% and 5.69%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
Shares of Health Catalyst (NASDAQ:HCAT) rose 2.39% in after-market trading after the company reported Q3 results. Quarterly Results Earnings per share rose 22.22% over the past year to ($0.21), which be...
SALT LAKE CITY, Nov. 10, 2020 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported finan...
Announces Promotion of Bryan Hunt as CFO and Additional Leadership Responsibilities to Support Continued Growth and Expansion Announces Promotion of Bryan Hunt as CFO and Additional Leadership Responsib...
Health Catalyst (HCAT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
SALT LAKE CITY, Nov. 02, 2020 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, t...
SALT LAKE CITY, Oct. 26, 2020 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, w...
SALT LAKE CITY, Oct. 22, 2020 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, annou...
As data is becoming more vital to healthcare, investors should consider buying "big data" stocks with high exposure to the sector. The post 3 Big Data Stocks Making Healthcare Better appeared first on I...
Yes, it's a leader with lots of momentum. But you need to understand this one key difference.
Health Catalyst - Looks Cheap But Where Is The Catalyst?
Health Catalyst, Inc. (HCAT) CEO Dan Burton on Q2 2020 Results - Earnings Call Transcript
Shares of Health Catalyst (NASDAQ:HCAT) fell 8.31% in after-market trading after the company reported Q2 results.
Health Catalyst (HCAT) delivered earnings and revenue surprises of 37.50% and 3.24%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
SALT LAKE CITY, Aug. 11, 2020 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (“Health Catalyst,” Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organization...
SALT LAKE CITY, Aug. 11, 2020 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported fin...
SALT LAKE CITY, Aug. 10, 2020 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations,...
Health Catalyst (HCAT) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Health Catalyst (HCAT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here we discuss three medical product stocks that are due to report soon and are likely to beat estimates on earnings, riding on a host of factors.
SALT LAKE CITY, July 29, 2020 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations,...
SALT LAKE CITY, July 28, 2020 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today...
As of late, it has definitely been a great time to be an investor in Health Catalyst.
SALT LAKE CITY, July 09, 2020 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (“Health Catalyst,” Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organization...
Big data is becoming a big factor in the healthcare industry.
Health Catalyst reported the results of its fiscal Q1 (ended 3/31) last week.
Health Catalyst - Helping Health Care Providers Manage Through The Covid-19 Crisis
Health Catalyst, Inc. (HCAT) CEO Dan Burton on Q1 2020 Results - Earnings Call Transcript
SALT LAKE CITY, May 12, 2020 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported fina...
About HCAT
Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations. Its solutions include a cloud-based data platform, analytics software, and professional services. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. The company was founded in 2008 and is headquartered in South Jordan, Utah.
| Industry Health Information Services | IPO Date Jul 25, 2019 |
| Stock Exchange NASDAQ | Ticker Symbol HCAT |
Financial Performance
In 2020, HCAT's revenue was $188.85 million, an increase of 21.88% compared to the previous year's $154.94 million. Losses were -$115.02 million, 91.4% more than in 2019.
Analyst Forecasts
According to 14 analysts, the average rating for HCAT stock is "Strong Buy." The 12-month stock price forecast is 57.00, which is an increase of 18.91% from the latest price.